Valuation : American Shared Hospital Services

Market Cap 10.04M 8.62M 8.09M 7.39M 13.94M 958M 14.01M 95.73M 37.1M 483M 37.7M 36.88M 1.6B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 10.04M 8.62M 8.09M 7.39M 13.94M 958M 14.01M 95.73M 37.1M 483M 37.7M 36.88M 1.6B EV / Sales 2026 *
0.31x
EV / Sales 2027 * -
Free-Float
65.28%
Yield 2026 *
-
Yield 2027 * -
1 day-2.32%
1 week-3.08%
Current month-2.33%
1 month-4.87%
3 months-1.68%
6 months-30.57%
Current year-30.57%
1 week 1.43
Extreme 1.43
1.54
1 month 1.43
Extreme 1.43
1.63
Current year 1.25
Extreme 1.25
2.39
1 year 1.25
Extreme 1.25
3.11
3 years 1.25
Extreme 1.25
4.6
5 years 1.25
Extreme 1.25
4.6
10 years 0
Extreme 0
5.04
Manager TitleAgeSince
Chief Executive Officer 72 27/04/2026
Director of Finance/CFO 42 07/07/2026
Sales & Marketing - 01/02/2023
Director TitleAgeSince
Chairman 68 07/03/2023
Director/Board Member 74 01/01/2016
Director/Board Member 69 28/12/2021
Date Insider Type Main position Quantity % Market Cap.
22/07/26 Free

Chairman

220,000 3.3208%
07/07/26 Other

Chief Financial Officer

9,634 0.1454%
26/06/25 Other

Chairman

110,000 1.7134%
Change 5-day change 1-year change 3-year change Capi.($)
-2.98%-3.08%-40.45%-44.40% 10.04M
-0.92%-4.30%+10.41%+129.31% 65.83B
-1.57%-4.95%-2.16%+4.00% 30.46B
+0.20%-3.33%+17.86%+24.60% 5.22B
+0.61%-0.66% - - 4.58B
-0.89%-3.67%+20.22%+67.67% 4.1B
-0.60%-2.58%-9.26%+10.29% 2.79B
+1.91%-1.84%-58.12%-15.79% 1.41B
-0.88%+0.52%+8.17%+285.79% 1.16B
+0.55%+2.99%+57.43%+122.63% 1.11B
Average -0.41%-2.96%+0.46%+64.90% 11.67B
Weighted average by Cap. -0.93%-4.80%+6.79%+84.88%

Financials

2026 *2027 *
Net sales 32.68M 28.05M 26.33M 24.05M 45.38M 3.12B 45.6M 312M 121M 1.57B 123M 120M 5.21B -
Net income - -
Net Debt - -
Logo American Shared Hospital Services
American Shared Hospital Services is a provider of turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). It can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The Company provides radiation therapy services both domestically and internationally.
Employees
83
Date Price Change Volume
27/08/26 $1.465 -2.98% 1,351
26/08/26 $1.510 +2.72% 3,842
25/08/26 $1.470 +2.80% 951
24/08/26 $1.430 -5.30% 4,823
21/08/26 $1.510 -0.10% 4,444

Quarterly revenue - Rate of surprise